Top

Journal of Cardiovascular Translational Research

Published in:

01-10-2014

Imaging Subclinical Atherosclerosis: Is It Ready for Prime Time? A Review

Authors: Leticia Fernández-Friera, Borja Ibáñez, Valentín Fuster

Published in: Journal of Cardiovascular Translational Research | Issue 7/2014

Abstract

Imaging subclinical atherosclerosis holds the promise of individualized cardiovascular (CV) risk assessment. The large arsenal of noninvasive imaging techniques available today is playing an increasingly important role in the diagnosis and monitoring of subclinical atherosclerosis. However, there is a debate about the advisability of clinical screens for subclinical atherosclerosis and which modality is the most appropriate for monitoring risk and atherosclerosis progression. This article offers an overview of the traditional and emerging noninvasive imaging modalities used to detect early atherosclerosis, surveys population studies addressing the value of subclinical atherosclerosis detection, and also examines guideline recommendations for their clinical implementation. The clinical relevance of this manuscript lies in the potential of current imaging technology to improve CV risk prediction based on traditional risk factors and the present recommendations for subclinical atherosclerosis assessment. Noninvasive imaging will also help to identify individuals at high CV who would benefit from intensive prevention or therapeutic interventions.

Foundation, B.H. (2005) European cardiovascular disease statistics.

Wilson, P. W., et al. (1998). Prediction of coronary heart disease using risk factor categories. Circulation, 97(18), 1837–1847.PubMedCrossRef

Sibley, C., et al. (2006). Limitations of current cardiovascular disease risk assessment strategies in women. Journal of Women's Health (2002), 15(1), 54–56.CrossRef

Berry, J. D., et al. (2009). Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Circulation, 119(3), 382–389.PubMedCrossRefPubMedCentral

Grover, S. A., Coupal, L., & Hu, X. P. (1995). Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work? JAMA, 274(10), 801–806.PubMedCrossRef

Khot, U. N., et al. (2003). Prevalence of conventional risk factors in patients with coronary heart disease. JAMA, 290(7), 898–904.PubMedCrossRef

Simon, A., Chironi, G., & Levenson, J. (2006). Performance of subclinical arterial disease detection as a screening test for coronary heart disease. Hypertension, 48(3), 392–396.PubMedCrossRef

Goff, D.C., Jr. et al. (2013) ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Journal of the American College of Cardiology.

Fuster, V., Lois, F., & Franco, M. (2010). Early identification of atherosclerotic disease by noninvasive imaging. Nature Reviews Cardiology, 7(6), 327–333.PubMedCrossRef

10.

Achenbach, S., et al. (2001). Noninvasive coronary angiography by magnetic resonance imaging, electron-beam computed tomography, and multislice computed tomography. American Journal of Cardiology, 88(2A), 70E–73E.PubMedCrossRef

11.

Ibanez, B., et al. (2007). [Novel imaging techniques for quantifying overall atherosclerotic burden]. Revista Española de Cardiología, 60(3), 299–309.CrossRef

12.

Yu, L., et al. (2009). Radiation dose reduction in computed tomography: techniques and future perspective. Medical Imaging, 1(1), 65–84.CrossRef

13.

Patel, S. N., et al. (2004). Emerging, noninvasive surrogate markers of atherosclerosis. Current Atherosclerosis Reports, 6(1), 60–68.PubMedCrossRef

14.

de Groot, E., et al. (2004). Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation, 109(23 Suppl 1), III33–III38.PubMed

15.

Baldassarre, D., et al. (2008). Carotid intima-media thickness and markers of inflammation, endothelial damage and hemostasis. Annals of Medicine, 40(1), 21–44.PubMedCrossRef

16.

Hodis, H. N., et al. (1998). The role of carotid arterial intima-media thickness in predicting clinical coronary events. Annals of Internal Medicine, 128(4), 262–269.PubMedCrossRef

17.

O’Leary, D. H., Cardiovascular Health Study Collaborative Research Group, et al. (1999). Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. New England Journal of Medicine, 340(1), 14–22.PubMedCrossRef

18.

Bots, M. L., Hofman, A., & Grobbee, D. E. (1994). Common carotid intima-media thickness and lower extremity arterial atherosclerosis. The Rotterdam Study. Arteriosclerosis and Thrombosis, 14(12), 1885–1891.PubMedCrossRef

19.

Baldassarre, D., et al. (2000). Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke, 31(10), 2426–2430.PubMedCrossRef

20.

Lorenz, M. W., et al. (2007). Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation, 115(4), 459–467.PubMedCrossRef

21.

Lind, L., et al. (2012). Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial. Journal of the American Society of Echocardiography, 25(10), 1120–1127 e1.PubMedCrossRef

22.

Smilde, T. J., et al. (2001). Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet, 357(9256), 577–581.PubMedCrossRef

23.

Raggi, P., et al. (2005). Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation, 112(4), 563–571.PubMedCrossRef

24.

Yerly, P., et al. (2013). Association between conventional risk factors and different ultrasound-based markers of atherosclerosis at carotid and femoral levels in a middle-aged population. International Journal of Cardiovascular Imaging, 29(3), 589–599.PubMedCrossRef

25.

Den Ruijter, H. M., et al. (2012). Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA, 308(8), 796–803.CrossRef

26.

Inaba, Y., Chen, J. A., & Bergmann, S. R. (2012). Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis, 220(1), 128–133.PubMedCrossRef

27.

Witte, D. R., et al. (2005). Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations? Journal of the American College of Cardiology, 45(12), 1987–1993.PubMedCrossRef

28.

Greenland, P., et al. (2010). ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation, 122(25), e584–e636.PubMedCrossRef

29.

Laurent, S., et al. (2006). Expert consensus document on arterial stiffness: methodological issues and clinical applications. European Heart Journal, 27(21), 2588–2605.PubMedCrossRef

30.

Ross, R. F., & Young, T. F. (1993). The nature and detection of mycoplasmal immunogens. Veterinary Microbiology, 37(3–4), 369–380.PubMedCrossRef

31.

Agatston, A. S., et al. (1990). Quantification of coronary artery calcium using ultrafast computed tomography. Journal of the American College of Cardiology, 15(4), 827–832.PubMedCrossRef

32.

Hoff, J. A., et al. (2001). Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults. American Journal of Cardiology, 87(12), 1335–1339.PubMedCrossRef

33.

Kondos, G. T., et al. (2003). Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation, 107(20), 2571–2576.PubMedCrossRef

34.

Wong, N. D., et al. (2000). Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. American Journal of Cardiology, 86(5), 495–498.PubMedCrossRef

35.

Arad, Y., et al. (2005). Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. Journal of the American College of Cardiology, 46(1), 158–165.PubMedCrossRef

36.

Greenland, P., et al. (2007). ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. Journal of the American College of Cardiology, 49(3), 378–402.PubMedCrossRef

37.

Bild, D. E., et al. (2005). Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation, 111(10), 1313–1320.PubMedCrossRef

38.

Fuster, V., et al. (2005). Atherothrombosis and high-risk plaque: Part II: approaches by noninvasive computed tomographic/magnetic resonance imaging. Journal of the American College of Cardiology, 46(7), 1209–1218.PubMedCrossRef

39.

Pletcher, M. J., et al. (2013). Interpretation of the coronary artery calcium score in combination with conventional cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation, 128(10), 1076–1084.PubMedCrossRef

40.

Hamon, M., et al. (2006). Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysis. Journal of the American College of Cardiology, 48(9), 1896–1910.PubMedCrossRef

41.

Prat-Gonzalez, S., Sanz, J., & Garcia, M. J. (2008). Cardiac CT: indications and limitations. Journal of Nuclear Medicine Technology, 36(1), 18–24.PubMedCrossRef

42.

Fernandez-Friera, L., et al. (2010). Lipid-rich obstructive coronary lesions is plaque characterization any important? JACC. Cardiovascular Imaging, 3(8), 893–895.PubMedCrossRef

43.

Hausleiter, J., et al. (2006). Radiation dose estimates from cardiac multislice computed tomography in daily practice: impact of different scanning protocols on effective dose estimates. Circulation, 113(10), 1305–1310.PubMedCrossRef

44.

Johri, A. M., et al. (2013). Can carotid bulb plaque assessment rule out significant coronary artery disease? A comparison of plaque quantification by two- and three-dimensional ultrasound. Journal of the American Society of Echocardiography, 26(1), 86–95.PubMedCrossRef

45.

Kalashyan, H., et al. (2014). Single sweep three-dimensional carotid ultrasound: reproducibility in plaque and artery volume measurements. Atherosclerosis, 232(2), 397–402.PubMedCrossRef

46.

Sillesen, H., et al. (2012). Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the high risk plaque BioImage study. JACC. Cardiovascular Imaging, 5(7), 681–689.PubMedCrossRef

47.

Makris, G. C., et al. (2011). Three-dimensional ultrasound imaging for the evaluation of carotid atherosclerosis. Atherosclerosis, 219(2), 377–383.PubMedCrossRef

48.

Corti, R., & Fuster, V. (2011). Imaging of atherosclerosis: magnetic resonance imaging. European Heart Journal, 32(14), 1709–19b.PubMedCrossRef

49.

Yuan, C., et al. (2001). In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation, 104(17), 2051–2056.PubMedCrossRef

50.

Fleg, J. L., et al. (2012). Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions. JACC. Cardiovascular Imaging, 5(9), 941–955.PubMedCrossRefPubMedCentral

51.

Corti, R., et al. (2005). Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. Journal of the American College of Cardiology, 46(1), 106–112.PubMedCrossRef

52.

Corti, R., et al. (2002). Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years’ follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation, 106(23), 2884–2887.PubMedCrossRef

53.

Underhill, H. R., et al. (2008). Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. American Heart Journal, 155(3), 584 e1–8.CrossRef

54.

Tang, T. Y., et al. (2008). Correlation of carotid atheromatous plaque inflammation using USPIO-enhanced MR imaging with degree of luminal stenosis. Stroke, 39(7), 2144–2147.PubMedCrossRef

55.

Tang, T. Y., et al. (2008). Correlation of carotid atheromatous plaque inflammation with biomechanical stress: utility of USPIO enhanced MR imaging and finite element analysis. Atherosclerosis, 196(2), 879–887.PubMedCrossRef

56.

Smith, B. R., et al. (2007). Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI). Biomedical Microdevices, 9(5), 719–727.PubMedCrossRef

57.

von Zur Muhlen, C., et al. (2007). Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. Atherosclerosis, 193(1), 102–111.CrossRef

58.

Briley-Saebo, K. C., et al. (2011). Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes. Journal of the American College of Cardiology, 57(3), 337–347.PubMedCrossRefPubMedCentral

59.

Hyafil, F., et al. (2011). Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases. European Heart Journal, 32(12), 1561–1571.PubMedCrossRefPubMedCentral

60.

von Bary, C., et al. (2011). MRI of coronary wall remodeling in a swine model of coronary injury using an elastin-binding contrast agent. Circulation. Cardiovascular Imaging, 4(2), 147–155.CrossRef

61.

Winter, P. M., et al. (2003). Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha (v) beta3-integrin-targeted nanoparticles. Circulation, 108(18), 2270–2274.PubMedCrossRef

62.

Rudd, J. H., et al. (2010). Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? Journal of the American College of Cardiology, 55(23), 2527–2535.PubMedCrossRef

63.

Mamede, M., et al. (2005). [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia, 7(4), 369–379.PubMedCrossRefPubMedCentral

64.

Ogawa, M., et al. (2004). (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. Journal of Nuclear Medicine, 45(7), 1245–1250.PubMed

65.

Tawakol, A., et al. (2005). Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. Journal of Nuclear Cardiology, 12(3), 294–301.PubMedCrossRef

66.

Rudd, J. H., et al. (2002). Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation, 105(23), 2708–2711.PubMedCrossRef

67.

Davies, J. R., et al. (2005). Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke, 36(12), 2642–2647.PubMedCrossRef

68.

Tahara, N., et al. (2006). Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. Journal of the American College of Cardiology, 48(9), 1825–1831.PubMedCrossRef

69.

Nikhil, V., & Joshi, T. A. (2014). Williams Michelle, et al., 18F-Fluoride positron emission tomography for identification of ruptured and high risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet, 383, 705–713.CrossRef

70.

Aikawa, E., et al. (2007). Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation, 116(24), 2841–2850.PubMedCrossRef

71.

Ripa, R. S., et al. (2013). Feasibility of simultaneous PET/MR of the carotid artery: first clinical experience and comparison to PET/CT. American Journal of Nuclear Medicine and Molecular Imaging, 3(4), 361–371.PubMedPubMedCentral

72.

The Atherosclerosis Risk in Communities (ARIC). (1989). Study: design and objectives. The ARIC investigators. American Journal of Epidemiology, 129(4), 687–702.

73.

Bild, D. E., et al. (2002). Multi-ethnic study of atherosclerosis: objectives and design. American Journal of Epidemiology, 156(9), 871–881.PubMedCrossRef

74.

Falk, E., et al. (2011). The high-risk plaque initiative: primary prevention of atherothrombotic events in the asymptomatic population. Current Atherosclerosis Reports, 13(5), 359–366.PubMedCrossRefPubMedCentral

75.

Ortiz, A., Jiménez-Borreguero, L., Peñalvo, J. L., Ordovas, J. M., Mocoroa, A., Fernandez-Friera, L., et al. (2013). The Progression and Early Detection of Subclinical Atherosclerosis (PESA) study: rationale and design. American Heart Journal, 133, 990–998.CrossRef

76.

Fuster, V., & Vahl, T. P. (2010). The role of noninvasive imaging in promoting cardiovascular health. Journal of Nuclear Cardiology, 17(5), 781–790.PubMedCrossRef

77.

Peters, S. A., et al. (2012). Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart, 98(3), 177–184.PubMedCrossRef

78.

Naghavi, M., et al. (2006). From vulnerable plaque to vulnerable patient—Part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. American Journal of Cardiology, 98(2A), 2H–15H.PubMedCrossRef

79.

Stein, J. H., et al. (2008). Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. Journal of the American Society of Echocardiography, 21(2), 93–111. quiz 189–90.PubMedCrossRef

80.

Perk, J., et al. (2012). European guidelines on cardiovascular disease prevention in clinical practice (version, The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). G Ital Cardiology (Rome), 14(5), 328–392.

81.

Sheikine, Y., & Akram, K. (2010). FDG-PET imaging of atherosclerosis: Do we know what we see? Atherosclerosis, 211(2), 371–380.PubMedCrossRef

82.

Ferket, B. S., et al. (2011). Systematic review of guidelines on imaging of asymptomatic coronary artery disease. Journal of the American College of Cardiology, 57(15), 1591–1600.PubMedCrossRef

83.

Hecht, H. S., et al. (2006). Coronary artery calcium scanning: clinical paradigms for cardiac risk assessment and treatment. American Heart Journal, 151(6), 1139–1146.PubMedCrossRef

84.

Taylor, A. J., et al. (2005). Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. Journal of the American College of Cardiology, 46(5), 807–814.PubMedCrossRef

85.

Raggi, P., et al. (2005). Progression of coronary artery calcium and occurrence of myocardial infarction in patients with and without diabetes mellitus. Hypertension, 46(1), 238–243.PubMedCrossRef

86.

Arad, Y., et al. (2005). Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. Journal of the American College of Cardiology, 46(1), 166–172.PubMedCrossRef

87.

Greenland, P., et al. (2000). Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation, 101(1), E16–E22.PubMedCrossRef

88.

Santos, R. D., & Nasir, K. (2009). Insights into atherosclerosis from invasive and non-invasive imaging studies: Should we treat subclinical atherosclerosis? Atherosclerosis, 205(2), 349–356.PubMedCrossRef

89.

Furberg, C. D., et al. (1994). Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation, 90(4), 1679–1687.PubMedCrossRef

90.

Salonen, R., et al. (1995). Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation, 92(7), 1758–1764.PubMedCrossRef

91.

Toth, P. P. (2008). Subclinical atherosclerosis: what it is, what it means and what we can do about it. International Journal of Clinical Practice, 62(8), 1246–1254.PubMedCrossRefPubMedCentral

92.

Taylor, A. J., et al. (2002). ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation, 106(16), 2055–2060.PubMedCrossRef

93.

Lauer, M. S. (2010). Screening asymptomatic subjects for subclinical atherosclerosis: not so obvious. Journal of the American College of Cardiology, 56(2), 106–108.PubMedCrossRef

Title: Imaging Subclinical Atherosclerosis: Is It Ready for Prime Time? A Review
Authors: Leticia Fernández-Friera
Borja Ibáñez
Valentín Fuster
Publication date: 01-10-2014
Publisher: Springer US
Published in: Journal of Cardiovascular Translational Research / Issue 7/2014
Print ISSN: 1937-5387
Electronic ISSN: 1937-5395
DOI: https://doi.org/10.1007/s12265-014-9582-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Imaging Subclinical Atherosclerosis: Is It Ready for Prime Time? A Review

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2014

Conditional Expression of the Type 2 Angiotensin II Receptor in Mesenchymal Stem Cells Inhibits Neointimal Formation After Arterial Injury

Application of Adipose-Derived Stem Cells in Heart Disease

Biological and Analytical Stability of a Peripheral Blood Gene Expression Score for Obstructive Coronary Artery Disease in the PREDICT and COMPASS Studies

Human Leukocyte Antigens and Alloimmunization in Heart Transplantation: An Open Debate

The Challenges of Autologous Cell Therapy: Systemic Anti-thrombotic Therapies Interfering with Serum Coagulation May Disable Autologous Serum-Containing Cell Products for Therapeutical Use

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page